Key result
Attained cardiomyocyte size suggests no limit on further ventricular hypertrophy.
Observational (n=104)
No
Cardiomyocyte hypertrophy reaches a limit in both ventricles that appears to be constrained by geometry and a fixed number of myocytes rather than attained cell size or contractile weakening.
Autopsy-derived myocyte limits should not change practice; leaves open mechanisms and clinical thresholds in living patients.
Cardiac myocytes respond to volume overload by undergoing hypertrophy in two phases: Proportionate increase in breadth and length and Continuation only of lengthening after the chamber dilates beyond a defined threshold.These responses have upper limits that are in need of explanation.Hearts were retrieved from 104 forensic autopsies.Myocyte breadths were measured in H&E-stained paraffin sections from LV and RV free walls.Mean myocyte lengths were calculated from chamber diameter and wall thickness (at full systole in these preparations) using a previously defined regression equation.Using body weight as an estimate for volume overload, myocyte breadth obeyed the expected two phase pattern.This pattern differed between ventricles in only one well defined way: the limiting mean breadths in the right and left respectively were 17.5 μm and 21.9 μm.Hence, in the RV it is not the attained size that imposed the limit on further hypertrophy of the mean myocyte because that attained size imposed no such limit in the LV.The behaviour of overworked myocytes is virtually identical in the two ventricles and it seems reasonable to propose that this identity should affect also the upper limit to size.Log normal distributions generally fit reasonably well in both RV and LV with no ceiling exerted upon the most enlarged cells, which further supports the lack of effect by attained size.A body of theory emerges which provisionally places a causal role for hypertrophy on the simple operation of geometry constrained by a fixed number of myocytes.The theory emerged without need to introduce any proposed contractile weakening.If this theory is confirmed by further observations using improved methodology then this conclusion would sharply constrain what subcellular mechanisms might mediate these events.
No takes yet. Share an insight, caveat, or question.
Richard E. Tracy (2016) conducted an observational in Cardiomegaly (n=104). Cardiomegaly / Volume overload vs. Non-cardiovascular cases without cardiomegaly was evaluated on Limiting mean myocyte breadth in right and left ventricles. The limiting mean cardiomyocyte breadths in the right and left ventricles were 17.5 μm and 21.9 μm, respectively, suggesting that attained size does not impose the limit on further hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: